PGK1 and Crohn disease: Importantly, exposure to UCB could reduce PGK1 and ALDOA levels in Th17 cells derived from the peripheral blood of healthy controls, after challenge with high concentration glucose; whereas such an effect was not present when considering Th17 cells derived from Crohn’s disease patients (Fig. 3f and Supplementary Fig. 3c, d).